Milltrust Invests into Green Bioactives
͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| - For Professional Investors Only - |
|
Milltrust Invests into Scottish Life Sciences Company, Green Bioactives Ltd. World-leaders in the discovery, development and sustainable creation of high-value plant cell cultures |
|
|
| |
|
|
| - We are pleased to announce a new investment for Milltrust’s Green Earth Ventures into Green Bioactives Ltd.
- Green Bioactives has created the world leading vascular stem cell technology that is integral to the sustainable biomanufacturing of plant biomolecules for commercial applications in the pharmaceutical, food, and agricultural industries.
- Alongside Milltrust, Green Bioactives has received investment from Eos Advisory, Regenerate Ventures, and Scottish Enterprise, as part of their seed financing to advance the sustainable plant products biomanufacturing platform.
- Green Bioactives is working with several world leading partners to produce high-value bioactives that cannot be produced sustainably or economically using other approaches. The company’s capabilities span initial isolation of the bioactive producing plant cells through to the supply of the final purified product.
- Green Bioactives was founded in 2020 and is the 3rd company backed by Milltrust that is based at the Roslin Innovation Centre, Edinburgh, Scotland, UK.
|
|
- David McElroy, CEO of Green Bioactives, commented: “This £2.6m seed funding is an incredibly exciting milestone for Green Bioactives, and we’re delighted to have attracted such a strong international investor base – demonstrating the global commercial potential of our plant cell culture-based biomanufacturing platform. The investment comes at a key time for the company, as we prepare for further growth and continue to develop our technology, working towards our goal of becoming the world’s leading supplier of safe, natural and sustainably-sourced plant-derived products”.
|
|
|
| |
|
|
| Milltrust International LLP
6 Stratton Street
London W1J 8LD
T: +44 (0)20 8123 8316
E: [email protected] |
|
Milltrust Ventures Pte. Ltd.
77B Tras Street
Singapore 079016
T: +65 9669 3186
E: [email protected] |
|
|
| |
|
|
| Disclaimer: For professional investors only. This document is strictly private and confidential and is meant as guidance and information only. It is issued by Milltrust International LLP which is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Milltrust International LLP has its registered office at 5 Market Yard Mews, 194-204 Bermondsey Street, London, SE1 3TQ, United Kingdom and is a subsidiary of Milltrust International Group (Singapore) Pte Ltd. Milltrust Ventures Pte Ltd is a subsidiary of Milltrust International Group (Singapore) Pte Ltd and is authorised and regulated by the Monetary Authority of Singapore. The content in this document is for informational purposes only and does not constitute legal, tax, investment, financial, or other advice. Nothing contained in this document constitutes a solicitation, recommendation, endorsement, or offer by Milltrust International LLP or any of its affiliates to buy or sell any securities or other financial instruments. No such solicitation or offer is made in this or in any other jurisdiction in which such solicitation or offer would be unlawful under the securities laws of such jurisdiction. All content in this document is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in the document constitutes professional and/or financial advice, nor does any information on the document constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. It should therefore not be used as the sole basis for any investment or other decision. The use of or access to this document or content by any person does not create a fiduciary relationship between such person and Milltrust International LLP. The sole responsibility of evaluating the merits and risks associated with the use of any information or other content on this document before making any decisions based on such information or other content rests with the user and their professional advisers.
|
|
|
| |
|
|
